Overall, we achieved a sensitivity of 95.35% (123/129) and a specificity of 98.67% (149/151) compared with HER2 status, which was determined by two pathologists who considered both IHC and FISH testing results in breast cancer (Table 1). Here, ERBB2 is linked to breast carcinoma.